Kidney Disease Clinical Trials

Showing 2661-2680 of 3,346 trials

Safety Study of RAD001 to Treat Patients With Metastatic Kidney Cancer

NCT00446368

Patients with metastatic renal cell cancer will be enrolled to receive RAD001 to determine whether the use of RAD001 will result in an improvement in the time to tumor progression.

Carcinoma, Renal Cell

The Methodist Hospital Research Institute66 participantsStarted May 2005

Houston, Texas, United States

COMPLETEDPhase 2

Study to Assess Fixed Dosing of AMG 223 in Subjects With Chronic Kidney Disease on Hemodialysis With Hyperphosphatemia

NCT00530114

The primary objectives of this study are the following: 1. To demonstrate that AMG 223 will produce a statistically significant reduction in serum phosphorus compared with placebo over a 3 week treatment period in subjects with CKD receiving dialysis 2. To describe a dose response for AMG 223 3. To evaluate the safety and tolerability of AMG 223

End Stage Renal DiseaseChronic Kidney DiseaseHyperphosphatemic+1 more

Amgen167 participantsStarted Mar 2008

TERMINATEDNA

Randomized Fistula Study

NCT00808561

The primary objective of this study is to compare two treatment strategies for establishing dialysis access in patients with unsuitable forearm veins for the standard forearm primary radio-cephalic arteriovenous fistula also known as the Brescia-Cimino fistula.

Renal Failure

University of Pittsburgh6 participantsStarted Dec 2008

Pittsburgh, Pennsylvania, United States

Safety Study of RAD001 to Treat Patients With Metastatic Kidney Cancer

Study to Assess Fixed Dosing of AMG 223 in Subjects With Chronic Kidney Disease on Hemodialysis With Hyperphosphatemia

Randomized Fistula Study

Related Searches

Observational Study of Correction of Anaemia With Darbepoetin Alfa at QM Dosing Interval in Patients With CKD Not on Dialysis

Cerebral Microembolism During Hemodialysis

Quantitative Imaging Metrics From CECT in Measuring Disease Response or Progression in Patients With Kidney Cancer

Effects of Omega 3 in Hemodialysis Patients

Treatment of Renal Sarcoidosis by Methylprednisolone Bolus

Red Blood Cell Lifespan

Pharmacokinetics and Safety of ABT-493 and ABT-530 in Subjects With Normal and Impaired Renal Function

Safety of Gadovist in Renally Impaired Patients

PaNeX: Partial Nephrectomy Under Xenon

Sirolimus Associated With Tacrolimus at Low Doses in Elderly Kidney Transplant Patients

A Multiple-Dose Study of Oral Oseltamivir in Participants on Hemodialysis (HD) and Continuous Ambulatory Peritoneal Dialysis (CAPD)

A Dose Escalation Study of VS-505 in End Stage Renal Disease Patients Undergoing Hemodialysis

Remote Ischemic Preconditioning in High Risk Cardiovascular Surgery Patients

Cytochrom p450 3A4 and 1A2 Phenotyping for the Individualization of Treatment With Sunitinib or Erlotinib in Cancer Patients

Early Renal Replacement Therapy and the Outcome of Acute Kidney Injury

Contrast-induced Nephropathy: Incidence,Risk Factors,Effective Prevention and Management Method

PrEvalence of Acute and Chronic Kidney Disease Treated by Renal Replacement Therapy